Filing Details
- Accession Number:
- 0001209191-20-063593
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-15 18:10:42
- Reporting Period:
- 2020-12-11
- Accepted Time:
- 2020-12-15 18:10:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
70318 | Tenet Healthcare Corp | THC | Services-General Medical & Surgical Hospitals, Nec (8062) | 952557091 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1568933 | T. Audrey Andrews | 14201 Dallas Parkway Dallas TX 75254 | Evp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-11 | 58,680 | $18.99 | 132,416 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-12-11 | 58,680 | $41.07 | 73,736 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-11 | 22,078 | $41.44 | 51,658 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | 2017 March Performance Stock Options (Right to Buy) | Disposition | 2020-12-11 | 58,680 | $18.99 | 58,680 | $18.99 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2020-02-28 | 2027-03-01 | No | 4 | M | Direct |
Footnotes
- This stock option was exercised and the resulting shares were sold in open market broker transactions.
- The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $40.98 to $41.32. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price
- These shares were sold in open market broker transactions.